CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		33,477
Beginning balance at Dec. 31, 2022	$ 211,605	$ 9	$ 1,182,568	$ 5,598	$ (976,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	8,381		8,381
Settlement of restricted stock (in shares)		168
Other comprehensive income (loss)	(1,274)			(1,274)
Net Income (Loss)	13,608				13,608
Ending balance (in shares) at Mar. 31, 2023		33,645
Ending balance at Mar. 31, 2023	232,320	$ 9	1,190,949	4,324	(962,962)
Beginning balance (in shares) at Dec. 31, 2023		39,728
Beginning balance at Dec. 31, 2023	134,798	$ 9	1,243,594	2,467	(1,111,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)		3
Stock Issued During Period, Value, Stock Options Exercised	5		5
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 12,256		12,256
Settlement of restricted stock (in shares)		943
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) (in shares)	3,592
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)	$ 27,451
Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) (in shares)	3,908
Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below)	$ 48,322
Other comprehensive income (loss)	580			580
Net Income (Loss)	(24,275)				(24,275)
Ending balance (in shares) at Mar. 31, 2024		48,174
Ending balance at Mar. 31, 2024	$ 199,137	$ 9	$ 1,331,628	$ 3,047	$ (1,135,547)